Boat joins PharmEasy, Droom to shelve listing plans amid valuation concerns
Rising Sebi scrutiny, poor investor response during roadshows seen as reasons for withdrawal by companies
)
Explore Business Standard
Rising Sebi scrutiny, poor investor response during roadshows seen as reasons for withdrawal by companies
)
First Published: Oct 28 2022 | 7:26 PM IST